Quick Answer
FATE THERAPEUTICS INC reported Revenue From Contract With Customer Excluding Assessed Tax of $6.65 million for the year ending 2025.
- FATE THERAPEUTICS INC showed a decrease of -51.2% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from FATE THERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 10 years of available data (2016 to 2025), FATE THERAPEUTICS INC's Revenue From Contract With Customer Excluding Assessed Tax has grown by 51.0%.
- Historical annual values: Fiscal year 2025: $6.65 million | Fiscal year 2024: $13.63 million | Fiscal year 2023: $63.53 million | Fiscal year 2022: $96.30 million | Fiscal year 2021: $55.85 million | Fiscal year 2020: $31.43 million | Fiscal year 2019: $10.68 million | Fiscal year 2018: $4.74 million | Fiscal year 2017: $4.11 million | Fiscal year 2016: $4.40 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: